Non-Hodgkin Lymphoma — Trials

Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

8,119 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,168
Recruiting: 1,128
Ph III recruiting: 115
Growth YoY: +8.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%
Trials / 1,000 deaths: 108.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,289)

clinicaltrialsPublishedShowing 1–50 of 123 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06474182	Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma(ProApix)	recruiting	N/A	36	Centre Hospitalier Universitaire de Saint EtienneOTHER	1	Sep 21, 2026	clinicaltrials
NCT07215494	A Clinical Study on Minimal Residual Disease in Patients With Systemic Light Chain Amyloidosis	recruiting	N/A	50	Peking University First HospitalOTHER	1	Sep 16, 2026